22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- Bonded by Blood: Remembering foreign heroes who fought with China
- What they say
- Digital tech helps link countries, boost trade
- SCO Summit to chart development blueprint
- China's 2025 summer box office surpasses 2024 as domestic films take the lead
- China targets online abuse of military veterans ahead of V-Day
